CN115572306A - Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane - Google Patents
Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane Download PDFInfo
- Publication number
- CN115572306A CN115572306A CN202211289012.1A CN202211289012A CN115572306A CN 115572306 A CN115572306 A CN 115572306A CN 202211289012 A CN202211289012 A CN 202211289012A CN 115572306 A CN115572306 A CN 115572306A
- Authority
- CN
- China
- Prior art keywords
- diethyl ester
- triethylene glycol
- acid diethyl
- volume ratio
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001308 synthesis method Methods 0.000 title claims description 9
- 239000006087 Silane Coupling Agent Substances 0.000 title abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 38
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 30
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 25
- -1 allyloxy triethylene glycol Chemical compound 0.000 claims abstract description 22
- LJDNMOCAQVXVKY-UHFFFAOYSA-N ethyl 2-[(2-ethoxy-2-oxoethyl)amino]acetate Chemical compound CCOC(=O)CNCC(=O)OCC LJDNMOCAQVXVKY-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims abstract description 14
- 239000011734 sodium Substances 0.000 claims abstract description 13
- KSCAZPYHLGGNPZ-UHFFFAOYSA-N 3-chloropropyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)CCCCl KSCAZPYHLGGNPZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 12
- MFFXVVHUKRKXCI-UHFFFAOYSA-N ethyl iodoacetate Chemical compound CCOC(=O)CI MFFXVVHUKRKXCI-UHFFFAOYSA-N 0.000 claims abstract description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 9
- 125000002252 acyl group Chemical group 0.000 claims abstract description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 7
- 239000012312 sodium hydride Substances 0.000 claims abstract description 7
- 229910000104 sodium hydride Inorganic materials 0.000 claims abstract description 7
- 239000003054 catalyst Substances 0.000 claims abstract description 6
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims abstract 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 60
- 235000019439 ethyl acetate Nutrition 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 22
- 238000004440 column chromatography Methods 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003208 petroleum Substances 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000741 silica gel Substances 0.000 claims description 9
- 229910002027 silica gel Inorganic materials 0.000 claims description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- 125000005336 allyloxy group Chemical group 0.000 claims description 8
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000005457 ice water Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000000376 reactant Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 claims 4
- DYHCCCWROHIOFM-UHFFFAOYSA-N 2-iodoethyl acetate Chemical compound CC(=O)OCCI DYHCCCWROHIOFM-UHFFFAOYSA-N 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- ZHSWSXCDJMIGPF-UHFFFAOYSA-N 1-[2-(2-hydroxyethoxy)ethoxy]-3-(oxiran-2-yl)propan-2-ol Chemical compound OCCOCCOCC(CC1OC1)O ZHSWSXCDJMIGPF-UHFFFAOYSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 238000004821 distillation Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 abstract description 5
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 abstract description 4
- ULQQGOGMQRGFFR-UHFFFAOYSA-N 2-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=CC=C1Cl ULQQGOGMQRGFFR-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002585 base Substances 0.000 abstract description 2
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 abstract 2
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 abstract 1
- 150000001282 organosilanes Chemical class 0.000 abstract 1
- 239000003444 phase transfer catalyst Substances 0.000 abstract 1
- 239000004032 superbase Substances 0.000 abstract 1
- 150000007525 superbases Chemical class 0.000 abstract 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 20
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 150000003961 organosilicon compounds Chemical class 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910002808 Si–O–Si Inorganic materials 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000013466 adhesive and sealant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- UCXUKTLCVSGCNR-UHFFFAOYSA-N diethylsilane Chemical compound CC[SiH2]CC UCXUKTLCVSGCNR-UHFFFAOYSA-N 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910021331 inorganic silicon compound Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
Description
技术领域technical field
本发明涉及化学合成技术领域,具体地说是一种新型硅烷偶联剂三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成方法。The invention relates to the technical field of chemical synthesis, in particular to a method for synthesizing a novel silane coupling agent trioxyl-triethoxyl-iminodiacetate diethyl organosilane.
背景技术Background technique
亚氨基二乙酸二乙酯是重要的医药、农药及材料的中间体、例如可以用于制备脑功能药荷拉西坦,同时也被广泛应用于表面活性剂、络合剂、食品添加剂、电镀工业金属表面处理、高分子材料工业、制药等领域。Diethyl iminodiacetate is an important intermediate of medicines, pesticides and materials. For example, it can be used to prepare the brain function drug Joracetam. Industrial metal surface treatment, polymer material industry, pharmaceuticals and other fields.
自然界中,诸如玻璃、石英、陶瓷等有许多无机物都含有Si-O-Si键,所以普遍都缺少有机基团,因而这些化合物都属于无机聚硅氧烷类。然而在在有机硅化学中需要在硅原子上连接机基团,从而形成硅氧烷类化合物,这类有机硅物质既能与无机物中的羟基又能与有机聚合物中的长分子链相互作用,使两种不同性质的材料偶联起来,从而改善生物材料的各种性能。因此,广泛应用在在橡胶、塑料、填充复合材料、环氧封装材料、弹性体、涂料、粘合剂和密封剂等方面。In nature, many inorganic substances such as glass, quartz, and ceramics contain Si-O-Si bonds, so they generally lack organic groups, so these compounds belong to the category of inorganic polysiloxanes. However, in organosilicon chemistry, it is necessary to connect organic groups to silicon atoms to form siloxane compounds, which can interact with both hydroxyl groups in inorganic substances and long molecular chains in organic polymers. Function, so that two materials with different properties are coupled to improve various properties of biomaterials. Therefore, it is widely used in rubber, plastics, filled composite materials, epoxy encapsulation materials, elastomers, coatings, adhesives and sealants, etc.
三乙基硅基广泛存在于有机化合物中,并且在有机合成中有重要的应用。硅杂环化合物因其独特的理化性质而被广泛地应用于有机合成化学、材料化学和药物化学中。因此,将含有三乙基硅基基团的有机化合物直接用于医药、农药等中间体合成的研究具有重要的意义。硅基化反应在化学合成法中能够保护特定官能团以降低沸点,增加化合物的挥发性,这一特性在医药、农药等领域作为中间体化合物中有重要的应用前景。Triethylsilyl exists widely in organic compounds and has important applications in organic synthesis. Silicon heterocyclic compounds are widely used in organic synthesis chemistry, materials chemistry and medicinal chemistry because of their unique physical and chemical properties. Therefore, it is of great significance to directly use organic compounds containing triethylsilyl groups in the synthesis of intermediates such as medicines and pesticides. The silylation reaction can protect specific functional groups in the chemical synthesis method to reduce the boiling point and increase the volatility of the compound. This feature has an important application prospect as an intermediate compound in the fields of medicine and pesticides.
研究表明,聚乙二醇(PEG)头基可以减少生物体内蛋白和亚氨基二乙酸二乙酯相互作用,所以在亚氨基二乙酸二乙酯上连接有PEG头基,可以降低生物药剂在进入靶点前的非特异性吸附,提高生物药剂的靶向性。Studies have shown that polyethylene glycol (PEG) head group can reduce the interaction between protein and diethyl iminodiacetate in the organism, so the PEG headgroup connected to diethyl iminodiacetate can reduce the entry of biological agents Non-specific adsorption in front of the target improves the targeting of biopharmaceuticals.
目前以亚氨基二乙酸二乙酯为指引头基,以聚乙二醇为间链、三乙基硅基为尾标的有机硅化合物未见相关合成报道。At present, there is no relevant synthesis report on organosilicon compounds with diethyl iminodiacetate as the head group, polyethylene glycol as the intermediate chain, and triethylsilyl as the tail.
发明内容Contents of the invention
本发明的目的是解决以亚氨基二乙酸二乙酯为指引头基,以聚乙二醇为间链、三乙基硅基为尾标的有机硅化合物的合成问题,提供一种三氧基-三乙氧基-亚胺二乙酸二乙酯硅烷的合成方法,解决在无机物质和有机物质的界面之间架起“分子桥”问题,对于实现在生物医药靶向识别和控释体系中的作用具有重要意义。The purpose of the present invention is to solve the synthetic problem of the organosilicon compound that takes diethyl iminodiacetate as the index head group, polyethylene glycol as the chain and triethylsilyl as the tail, and provides a trioxyl- The synthesis method of triethoxy-iminodiacetate diethyl silane solves the problem of building a "molecular bridge" between the interface of inorganic substances and organic substances, and plays a role in realizing the target recognition and controlled release system of biomedicine is of great significance.
通过上述合成的有机硅化合物,可在无机物质和有机物质的界面之间架起“分子桥”,把两种性质完全不同的材料连接在一起。三乙基硅基、亚氨基二乙酸二乙酯和以聚乙二醇的有机官能团的反应基团可以决定此化合物在生物医药、农药靶向识别和控释体系中所起的靶点作用。Through the organosilicon compound synthesized above, a "molecular bridge" can be built between the interface of inorganic substances and organic substances, and two materials with completely different properties can be connected together. The reactive groups of triethylsilyl group, diethyl iminodiacetate and polyethylene glycol organic functional group can determine the target function of this compound in biomedicine, pesticide targeted recognition and controlled release system.
三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷具有活性优异,常温下结构稳定,立体选择性好,形成的偶联体系稳定性高等诸多优点。该合成方法可用于合成系列硅烷基链、可变聚乙二醇间链等硅烷偶联剂,在有机硅化合物合成研究领域有重要的作用。因此,研究三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成方法,将填补该类有机硅化合物通过无机硅连接技术探究无机物质和有机物质的界面间“分子桥”作用,为医药和农药领域精准给药开辟新的研究应用途径。Trioxy-triethoxy-iminodiacetate diethyl organosilane has many advantages such as excellent activity, stable structure at room temperature, good stereoselectivity, and high stability of the formed coupling system. The synthesis method can be used to synthesize a series of silane coupling agents such as silyl chains and variable polyethylene glycol chains, and plays an important role in the field of organosilicon compound synthesis research. Therefore, the study of the synthesis method of trioxy-triethoxy-iminodiacetate diethyl organosilane will fill in the "molecular bridge" between the interface of inorganic substances and organic substances through the connection technology of inorganic silicon compounds. It will open up a new research and application path for precise drug delivery in the field of medicine and pesticides.
本发明是通过下述技术方案实现的:The present invention is achieved through the following technical solutions:
碘乙酸乙酯与烯丙氧基三甘醇在N,N-二甲基甲酰胺(DMF)中以1,8-二氮杂双环[5.4.0]十一碳-7-烯(DBU)作为催化剂的系列反应中合成烯丙氧基三甘醇酰基亚氨二乙酸二乙酯。此衍生物与氯过氧苯甲酸(MCPBA)和三苯基磷(Ph3P)相继混合,在以氢化钠为强碱条件,以三氟化硼合乙醚(BF3·C2H6O)为催化剂,合成得到环氧丙基三甘醇酰基亚氨二乙酸二乙酯。最后在超强碱钠块条件下与(3-氯丙基)三乙氧基硅烷混合,在相转移催化剂苄基三乙基氯化铵(TEBA)催化下反应制得目标产物三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷。本发明制备的三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷结构式如下所示:Ethyl iodoacetate and allyloxytriethylene glycol in N,N-dimethylformamide (DMF) as 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) Synthesis of diethyl allyloxytriglycolyl iminodiacetate in a series of reactions as a catalyst. This derivative is mixed with chloroperoxybenzoic acid (MCPBA) and triphenylphosphine (Ph 3 P) successively, under the condition of sodium hydride as a strong base, boron trifluoride diethyl ether (BF 3 · C 2 H 6 O ) as a catalyst, synthesized to obtain diethyl glycidyl triethylene glycol acyl iminodiacetate. Finally, it is mixed with (3-chloropropyl) triethoxysilane under super alkali sodium block conditions, and the target product trioxy- Triethoxy-diethyliminodiacetate organosilane. The trioxy-triethoxy-iminodiacetate diethyl organosilane structural formula prepared by the present invention is as follows:
所述的三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成方法,包括如下步骤:The synthetic method of described trioxy-triethoxy-iminodiacetate diethyl organosilane comprises the steps:
1)烯丙氧基三甘醇TG-Ally的合成1) Synthesis of allyloxytriethylene glycol TG-Ally
三甘醇溶解在干燥的四氢呋喃(THF)中,室温下搅拌30min后加入纯钠快速搅拌1h,滴加烯丙基溴,继续反应6h;减压蒸馏后的残留物用二氯甲烷溶解,用饱和氯化钠(NaCl)溶液洗涤,无水硫酸镁干燥,过滤浓缩后柱层析提纯;Dissolve triethylene glycol in dry tetrahydrofuran (THF), stir at room temperature for 30 minutes, add pure sodium and stir rapidly for 1 hour, add allyl bromide dropwise, and continue the reaction for 6 hours; the residue after vacuum distillation is dissolved in dichloromethane, and Wash with saturated sodium chloride (NaCl) solution, dry over anhydrous magnesium sulfate, filter and concentrate, and purify by column chromatography;
2)烯丙氧基三甘醇酰基亚氨二乙酸二乙酯的合成2) Synthesis of allyloxy triglycolic iminodiacetic acid diethyl ester
碘乙酸乙酯和TG-Ally混合后溶解在干燥的DMF中,0℃下搅拌1~2h(优选1.5h),快速加入催化剂量的DBU,常温下连续搅拌24h后,加入95%乙醇溶液解多余DBU,用饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤浓缩柱层析,洗脱剂为乙酸乙酯/石油醚。Mix ethyl iodoacetate and TG-Ally and dissolve in dry DMF, stir at 0°C for 1-2h (preferably 1.5h), quickly add a catalytic amount of DBU, stir continuously at room temperature for 24h, then add 95% ethanol solution to decompose Excess DBU was washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered and concentrated by column chromatography, and the eluent was ethyl acetate/petroleum ether.
3)环氧丙基三甘醇酰基亚氨二乙酸二乙酯的合成3) Synthesis of Epoxypropyl Triethylene Glycoyl Iminodiacetate Diethyl Ester
烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与Ph3P和MCPBA混合后溶于干燥二氯甲烷中,随后加入适量氢化钠粉末,缓慢加热至30℃~50℃(优选40℃),快速搅拌30min,逐滴快速加入BF3·C2H6O,滴加完毕后在室温下连续搅拌30h,反应产物在冰水混合物中冷却至0℃后过滤;将浓缩后的滤液利用混合有机溶剂萃取,有机相通过减压蒸馏。Diethyl allyloxytriglycolyl iminodiacetate is mixed with Ph 3 P and MCPBA and dissolved in dry dichloromethane, then an appropriate amount of sodium hydride powder is added, and slowly heated to 30°C-50°C (preferably 40°C ), stirred rapidly for 30min, quickly added BF 3 · C 2 H 6 O dropwise, and stirred continuously at room temperature for 30h after the dropwise addition, and filtered the reaction product after cooling to 0°C in an ice-water mixture; the concentrated filtrate was used Mixed organic solvents were extracted, and the organic phase was distilled under reduced pressure.
4)三氧基-三乙氧基-亚胺二乙酸二乙酯硅烷的合成4) Synthesis of trioxy-triethoxy-iminodiacetate diethyl silane
环氧丙基三甘醇酰基亚氨二乙酸二乙酯与(3-氯丙基)三乙氧基硅烷溶解在无水DMF中,50℃~80℃(优选60℃)下搅拌2h后,加入催化剂量苄基三乙基氯化铵(TEBA),持续搅拌12h。反应物用饱和碳酸氢钠溶液洗涤,有机相减压浓缩后过滤、浓缩后经柱层析分离,放置冷冻室内3h,得到白色固体。Diethyl glycidyl triglycolyl iminodiacetate and (3-chloropropyl) triethoxysilane were dissolved in anhydrous DMF, and stirred at 50°C to 80°C (preferably 60°C) for 2 hours, A catalytic amount of benzyltriethylammonium chloride (TEBA) was added and stirring continued for 12h. The reactant was washed with saturated sodium bicarbonate solution, the organic phase was concentrated under reduced pressure, filtered, concentrated, separated by column chromatography, and placed in a freezer for 3 hours to obtain a white solid.
进一步地,所述的步骤1)中,Further, in the described step 1),
三甘醇与烯丙基溴的体积比1mL:1.3-2mL;优选1mL:1.5mL。The volume ratio of triethylene glycol to allyl bromide 1 mL: 1.3-2 mL; preferably 1 mL: 1.5 mL.
钠块与三甘醇的质量体积比为1g:2-3mL;优选1g:2.8mL;The mass volume ratio of sodium block to triethylene glycol is 1g: 2-3mL; preferably 1g: 2.8mL;
THF与三甘醇的体积比为3-3.5mL:1mL;优选3mL:1mL。The volume ratio of THF to triethylene glycol is 3-3.5mL: 1mL; preferably 3mL: 1mL.
柱层析中,采用硅胶、EtOAc和EtOAc,其中EtOAc和EtOAc的体积比v/v为1:1。In column chromatography, silica gel, EtOAc and EtOAc are used, wherein the volume ratio v/v of EtOAc and EtOAc is 1:1.
进一步地,所述的步骤2)中,Further, in the described step 2),
碘乙酸乙酯和TG-Ally的质量比1g:2-3g;优选1g:2.5g。The mass ratio of ethyl iodoacetate to TG-Ally is 1g:2-3g; preferably 1g:2.5g.
溶剂DMF必须是无水的;The solvent DMF must be anhydrous;
DMF与碘乙酸乙酯的体积质量比为1mL:0.02-0.05g;优选1mL:0.05g;The volume-to-mass ratio of DMF to ethyl iodoacetate is 1 mL: 0.02-0.05 g; preferably 1 mL: 0.05 g;
DBU与TG-Allyl的体积质量比为1μL:0.5g-1.30g;优选1μL:1.25g;The volume-to-mass ratio of DBU to TG-Allyl is 1 μL: 0.5g-1.30g; preferably 1 μL: 1.25g;
95%乙醇溶液与DBU的体积比为1μL:1μL;The volume ratio of 95% ethanol solution to DBU is 1 μL: 1 μL;
柱层析中,采用硅胶、EtOAc和Petroleum,其中EtOAc和Petroleum的体积比v/v为1:2。In column chromatography, silica gel, EtOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1:2.
进一步地,所述的步骤3)中,Further, in the described step 3),
烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与MCPBA质量比为1g:0.5-1g,优选1g:1g。The mass ratio of allyloxytriglycolyl iminodiacetate to MCPBA is 1g:0.5-1g, preferably 1g:1g.
烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与Ph3P质量比为1g:1.5-2g,优选1g:2g。The mass ratio of allyloxytriglycolyl iminodiacetic acid diethyl ester to Ph 3 P is 1g:1.5-2g, preferably 1g:2g.
萃取滤液的混合有机溶剂为乙醚/乙酸乙酯,体积比v/v为1:1。The mixed organic solvent for extracting the filtrate is diethyl ether/ethyl acetate, and the volume ratio v/v is 1:1.
进一步地,所述的步骤4)中,Further, in the described step 4),
环氧丙基三甘醇酰基亚氨二乙酸二乙酯与(3-氯丙基)三乙氧基硅烷的体积比为15:1。The volume ratio of diethyl glycidyl triglycolyl iminodiacetate to (3-chloropropyl)triethoxysilane is 15:1.
DMF与环氧丙基三甘醇酰基亚氨二乙酸二乙酯的体积比为4-4.5mL:3mL;优选4mL:3mLThe volume ratio of DMF to diethyl glycidyl triglycolyl iminodiacetate is 4-4.5mL: 3mL; preferably 4mL: 3mL
(3-氯丙基)三乙氧基硅烷与TEBA体积质量比为1mL:0.1-0.3g,优选1mL:0.2g。The volume/mass ratio of (3-chloropropyl)triethoxysilane to TEBA is 1 mL: 0.1-0.3 g, preferably 1 mL: 0.2 g.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1)本发明合成三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷是制备硅树脂固胰酶载体的重要原料,可使固化酶不溶于水,未失活的固相酶经过滤后还可继续使用,不仅提高了生物酶的利用率,还能减少环境污染和原料浪费,该合成方法填补了现有技术中有机硅中含亚氨基二乙酸二乙酯的偶联剂化合物合成空白。1) The synthesis of trioxy-triethoxy-iminodiacetate diethyl organosilane of the present invention is an important raw material for the preparation of silicone resin-solidified trypsin carrier, which can make the solidified enzyme insoluble in water and not inactivated solid-phase enzyme It can be used continuously after filtration, which not only improves the utilization rate of biological enzymes, but also reduces environmental pollution and waste of raw materials. This synthesis method fills the coupling agent containing diethyl iminodiacetate in organosilicon in the prior art. Compound synthesis blank.
2)本发明的方法步骤少、操作简便效率高,所需原料及催化剂较常规,低毒或无毒,后续处理简单易回收,产品收率高,突破生物医药类有机硅类化合物合成方法复杂、复杂繁琐且产率较低的限制。2) The method of the present invention has few steps, simple operation and high efficiency, relatively conventional raw materials and catalysts, low toxicity or non-toxicity, simple and easy recovery in follow-up treatment, high product yield, and a breakthrough in the synthesis method of biomedical organosilicon compounds. , complex and cumbersome and low yield limitations.
附图说明Description of drawings
图1为实施例1制备的最终产物的核磁共振检测图谱。Fig. 1 is the NMR detection spectrum of the final product prepared in Example 1.
具体实施方式detailed description
为了使本发明的目的、技术方案及优点更加清晰明了,以下结合附图及实施例,对本发明进行进一步详细说明,显然,所描述的实施例仅是本发明一部分实施例,而不是全部的实施例。In order to make the purpose, technical solutions and advantages of the present invention clearer, the present invention will be described in further detail below in conjunction with the accompanying drawings and embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. example.
实施例1Example 1
(1)烯丙氧基三甘醇TG-Ally的合成(1) Synthesis of allyloxytriethylene glycol TG-Ally
10mL三甘醇溶解在30mL干燥的THF中,室温下搅拌30min后加入3.5g纯钠快速搅拌1h,滴加15mL烯丙基溴,继续反应6h。减压蒸馏后的残留物用30mL二氯甲烷溶解,用饱和NaCl溶液洗涤,无水硫酸镁干燥,过滤浓缩后柱层析提纯得到无色油状产物4g,产率80%。Dissolve 10 mL of triethylene glycol in 30 mL of dry THF, stir at room temperature for 30 min, add 3.5 g of pure sodium and stir rapidly for 1 h, add dropwise 15 mL of allyl bromide, and continue the reaction for 6 h. The residue after vacuum distillation was dissolved in 30 mL of dichloromethane, washed with saturated NaCl solution, dried over anhydrous magnesium sulfate, filtered and concentrated, and purified by column chromatography to obtain 4 g of a colorless oily product with a yield of 80%.
柱层析中,采用硅胶、EtOAc和EtOAc,其中EtOAc和EtOAc的体积比v/v为1:1。In column chromatography, silica gel, EtOAc and EtOAc are used, wherein the volume ratio v/v of EtOAc and EtOAc is 1:1.
(2)烯丙氧基三甘醇酰基亚氨二乙酸二乙酯的合成(2) Synthesis of allyloxy triglycolic iminodiacetic acid diethyl ester
0.5g碘乙酸乙酯和1.25g TG-Ally混合后溶解在10mL干燥的无水DMF中,0℃下搅拌1.5h,快速滴加1μL DBU,连续搅拌24h后,加入1μL 95%乙醇溶分解多余DBU,用饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤浓缩柱层析得到无色粘稠状产物0.4g,产率为75%。Mix 0.5g of ethyl iodoacetate and 1.25g of TG-Ally and dissolve in 10mL of dry anhydrous DMF, stir at 0°C for 1.5h, quickly add 1μL of DBU dropwise, continue stirring for 24h, add 1μL of 95% ethanol to dissolve excess DBU, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered and concentrated column chromatography gave 0.4 g of a colorless viscous product with a yield of 75%.
柱层析中,采用硅胶、EtOAc和Petroleum,其中EtOAc和Petroleum的体积比v/v为1:2。In column chromatography, silica gel, EtOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1:2.
(3)环氧丙基三甘醇酰基亚氨二乙酸二乙酯的合成(3) Synthesis of Epoxypropyl Triglycolyl Iminodiacetate Diethyl Ester
5g的烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与5g MCPBA和10gPh3P先后混合后溶于30ml的二氯甲烷中,将0.5g氢化钠粉末迅速加入溶液中,缓慢加热至40℃,快速搅拌30min,然后滴加50μL BF3·C2H6O,滴加完毕后在室温下连续搅拌30h。利用冰水混合物冷却至0℃后过滤,将浓缩后的滤液与20ml蒸馏水混合,利用乙醚/乙酸乙酯混合溶剂(v/v=1:1)萃取。含水相通过减压蒸馏获得透明固体产物3g,产率为80%。5g of allyloxy triglycolyl iminodiacetic acid diethyl ester mixed with 5g MCPBA and 10gPh 3 P successively and dissolved in 30ml of dichloromethane, 0.5g of sodium hydride powder was quickly added to the solution, slowly heated to Stir rapidly at 40°C for 30 min, then add 50 μL of BF 3 · C 2 H 6 O dropwise, and continue stirring at room temperature for 30 h after the dropwise addition. After cooling to 0° C. with ice-water mixture, filter, mix the concentrated filtrate with 20 ml of distilled water, and extract with diethyl ether/ethyl acetate mixed solvent (v/v=1:1). The aqueous phase was distilled under reduced pressure to obtain 3 g of a transparent solid product with a yield of 80%.
(4)三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成(4) Synthesis of trioxy-triethoxy-iminodiacetate diethyl organosilane
7.5ml环氧丙基三甘醇酰基亚氨二乙酸二乙酯与0.5ml(3-氯丙基)三乙氧基硅烷依次溶解在10ml无水DMF中,60℃下搅拌2h后,缓慢加入0.1g的TEBA,持续搅拌12h,反应物用饱和碳酸氢钠溶液洗涤,有机相减压浓缩后过滤,浓缩后经柱层析分离,放置冷冻室内3h,得到白色固体2g。产率为70%。7.5ml of diethyl epoxypropyl triglycolyl iminodiacetate and 0.5ml of (3-chloropropyl)triethoxysilane were dissolved in 10ml of anhydrous DMF in turn, stirred at 60°C for 2h, then slowly added 0.1 g of TEBA was continuously stirred for 12 hours, the reactant was washed with saturated sodium bicarbonate solution, the organic phase was concentrated under reduced pressure and then filtered. After concentration, it was separated by column chromatography and placed in a freezer for 3 hours to obtain 2 g of white solid. The yield was 70%.
1H NMR(500MHz,CDCl3):δ4.44–4.51(s,2H;H-2);4.08–4.18(d,J=12.2Hz,4H;H-1);3.78–3.88(m,2H;2CH2,ethoxy);3.32–3.40(m,2H;CH,acetyl),1.50–1.51(m,4H;2OCH2),1.48(m,4H;OCH2CH2)1.26–1.31(brs,12H;CH3),1.18–1.23(t,3J=6.8Hz,9H;CH3);0.56–0.60(t,3J=6.05and 6.8Hz,2H;CH2). 1 H NMR (500MHz, CDCl 3 ): δ4.44–4.51 (s, 2H; H-2); 4.08–4.18 (d, J=12.2Hz, 4H; H-1); 3.78–3.88 (m, 2H ; 2CH2, ethoxy); 3.32–3.40 (m, 2H; CH, acetyl), 1.50–1.51 (m, 4H; 2OCH2), 1.48 (m, 4H; OCH2CH2), 1.26–1.31 (brs, 12H; CH3), 1.18 –1.23(t,3J=6.8Hz,9H;CH3); 0.56–0.60(t,3J=6.05and 6.8Hz,2H;CH2).
柱层析中,采用硅胶、EtOAc和CH3OH,其中EtOAc和CH3OH的体积比v/v为1:1,Rf=0.48In column chromatography, silica gel, EtOAc and CH 3 OH are used, wherein the volume ratio v/v of EtOAc and CH 3 OH is 1:1, R f =0.48
从图1和上述数据结果,可以看出:依据本发明的合成方法获得的最终产物符合目标物质特征。From Fig. 1 and the above data results, it can be seen that the final product obtained according to the synthesis method of the present invention meets the characteristics of the target substance.
应用例1六氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成Application example 1 Synthesis of hexaoxy-triethoxy-iminodiacetate diethyl organosilane
(1)烯丙氧基聚六甘醇的合成(1) Synthesis of allyloxy polyhexaethylene glycol
10mL聚六甘醇溶解在30mL干燥的THF中,室温下搅拌60min后加入3.5g纯钠快速搅拌1h,滴加15mL烯丙基溴,继续反应6h。减压蒸馏后的残留物用30mL二氯甲烷溶解,用饱和NaCl溶液洗涤,无水硫酸镁干燥,过滤浓缩后重结晶提纯得到无色固体产物3g,产率70%。Dissolve 10mL of polyhexaethylene glycol in 30mL of dry THF, stir at room temperature for 60min, add 3.5g of pure sodium and stir rapidly for 1h, add dropwise 15mL of allyl bromide, and continue the reaction for 6h. The residue after vacuum distillation was dissolved in 30 mL of dichloromethane, washed with saturated NaCl solution, dried over anhydrous magnesium sulfate, concentrated by filtration and purified by recrystallization to obtain 3 g of a colorless solid product with a yield of 70%.
重结晶溶剂:石油醚(30-60℃)Recrystallization solvent: petroleum ether (30-60°C)
(2)烯丙氧基聚六甘醇酰基亚氨二乙酸二乙酯的合成(2) Synthesis of allyloxy polyhexaethylene glycol acyl iminodiacetate diethyl
0.5g碘乙酸乙酯和1.25g烯丙氧基聚六甘醇混合后溶解在10mL干燥的DMF中,室温搅拌30min,快速滴加DBU,连续搅拌24h后,加入95%乙醇溶分解多余DBU,用饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤浓缩柱层析得到无色针状产物0.5g,产率为80%。Mix 0.5g of ethyl iodoacetate and 1.25g of allyloxy polyhexaethylene glycol, dissolve in 10mL of dry DMF, stir at room temperature for 30min, and add dropwise quickly DBU, after continuous stirring for 24h, add The excess DBU was dissolved in 95% ethanol, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered and concentrated column chromatography to obtain 0.5 g of a colorless needle product with a yield of 80%.
柱层析中,采用硅胶、EtOAc和Petroleum,其中EtOAc和Petroleum的体积比v/v为1:1。In column chromatography, silica gel, EtOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1:1.
(3)环氧丙基聚六甘醇酰基亚氨二乙酸二乙酯的合成(3) Synthesis of glycidyl polyhexaethylene glycol acyl iminodiacetate diethyl
5g的烯丙氧基聚六甘醇酰基亚氨二乙酸二乙酯与5g MCPBA和10gPh3P先后混合后溶于30ml的二氯甲烷中,将0.5g氢化钠粉末迅速加入溶液中,缓慢加热至40℃,快速搅拌30min,然后滴加50μL BF3·C2H6O,滴加完毕后在室温下连续搅拌30h。利用冰水混合物冷却至0℃后过滤,将浓缩后的滤液与20ml蒸馏水混合,利用乙醚/乙酸乙酯混合溶剂(v/v=1:1)萃取。含水相通过减压蒸馏获得片状白色固体产物2g,产率为60%。5g of allyloxy polyhexaethylene glycol acyl iminodiacetic acid diethyl acetate, 5g of MCPBA and 10g of Ph 3 P were mixed successively and dissolved in 30ml of dichloromethane, 0.5g of sodium hydride powder was quickly added to the solution, and slowly heated to 40°C, stirred rapidly for 30 min, then added 50 μL of BF 3 · C 2 H 6 O dropwise, and stirred continuously at room temperature for 30 h after the dropwise addition. After cooling to 0° C. with ice-water mixture, filter, mix the concentrated filtrate with 20 ml of distilled water, and extract with diethyl ether/ethyl acetate mixed solvent (v/v=1:1). The aqueous phase was distilled under reduced pressure to obtain 2 g of a flaky white solid product with a yield of 60%.
(4)六氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成(4) Synthesis of hexaoxy-triethoxy-iminodiacetate diethyl organosilane
7.5ml环氧丙基聚六甘醇酰基亚氨二乙酸二乙酯与0.5ml(3-氯丙基)三乙氧基硅烷依次溶解在10ml无水DMF中,60℃下搅拌2h后,缓慢加入0.1g的TEBA,持续搅拌12h,反应物用饱和碳酸氢钠溶液洗涤,有机相减压浓缩后过滤,浓缩后经柱层析分离,放置冷冻室内3h,得到白色固体0.5g。产率为60%。Dissolve 7.5ml of glycidyl polyhexaglycolyl iminodiacetic acid diethyl ester and 0.5ml (3-chloropropyl)triethoxysilane in 10ml of anhydrous DMF in turn, stir at 60°C for 2h, slowly Add 0.1 g of TEBA, continue to stir for 12 h, wash the reactant with saturated sodium bicarbonate solution, concentrate the organic phase under reduced pressure, and filter it. After concentration, it is separated by column chromatography and placed in a freezer for 3 h to obtain 0.5 g of a white solid. The yield was 60%.
1H NMR(500MHz,CDCl3):δ4.50(s,8H;H-2),4.40(12H;H-1),4.13(d,J=12.2Hz,4H;H-1),3.80–3.83(m,2H;2CH2,ethoxy),3.38–3.40(m,2H;CH,acetyl),1(m,4H;2OCH2),1.50–1.53(m,4H;OCH2CH2),1.19–1.22(brs,12H;CH3),0.50(t,3J=6.05and 6.8Hz,2H;CH2).1.20–1.21(t,3J=6.8Hz,9H;CH3) 1 H NMR (500MHz, CDCl 3 ): δ4.50(s, 8H; H-2), 4.40(12H; H-1), 4.13(d, J=12.2Hz, 4H; H-1), 3.80– 3.83 (m, 2H; 2CH 2 , ethoxy), 3.38–3.40 (m, 2H; CH, acetyl), 1 (m, 4H; 2OCH 2 ), 1.50–1.53 (m, 4H; OCH 2 CH 2 ), 1.19 –1.22(brs,12H; CH 3 ), 0.50(t, 3 J=6.05 and 6.8Hz,2H; CH 2 ).1.20–1.21(t, 3 J=6.8Hz,9H; CH 3 )
柱层析中,采用硅胶、EtOAc和CH3OH,其中EtOAc和CH3OH的体积比v/v为1:1,Rf=0.53.In column chromatography, silica gel, EtOAc and CH 3 OH are used, wherein the volume ratio v/v of EtOAc and CH 3 OH is 1:1, R f =0.53.
以上仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围内。The above are only examples of the present invention, and are not intended to limit the patent scope of the present invention. All equivalent transformations made using the content of the description of the present invention, or directly or indirectly used in other related technical fields, are equally included in the scope of the present invention. within the scope of patent protection.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211289012.1A CN115572306A (en) | 2022-10-20 | 2022-10-20 | Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211289012.1A CN115572306A (en) | 2022-10-20 | 2022-10-20 | Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115572306A true CN115572306A (en) | 2023-01-06 |
Family
ID=84586676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211289012.1A Pending CN115572306A (en) | 2022-10-20 | 2022-10-20 | Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115572306A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110540549A (en) * | 2019-10-10 | 2019-12-06 | 山东大学 | A kind of coumarin-based bridged silane and its preparation method |
CN112047974A (en) * | 2020-09-09 | 2020-12-08 | 山东大学 | Photodegradable bridged silane and preparation method thereof |
-
2022
- 2022-10-20 CN CN202211289012.1A patent/CN115572306A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110540549A (en) * | 2019-10-10 | 2019-12-06 | 山东大学 | A kind of coumarin-based bridged silane and its preparation method |
CN112047974A (en) * | 2020-09-09 | 2020-12-08 | 山东大学 | Photodegradable bridged silane and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066971A (en) | Non-enantioselective prepn process of emtricitabine | |
CN110776528A (en) | Ammonium sulfonate zwitterionic silane coupling agent, siloxane ring body and preparation method thereof | |
CN112812107B (en) | Preparation method of SGLT-2 inhibitor and intermediate | |
CN113061111A (en) | Method for preparing amino acid compound with photocrosslinking activity | |
CN1137887C (en) | A kind of improved method of synthesizing valsartan | |
CN115947759A (en) | Preparation method of medicine Ruidexiwei for treating new coronary disease | |
CN115572306A (en) | Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane | |
CN109476687B (en) | Preparation method of chiral phosphate | |
CN111170893B (en) | Lefamulin intermediate compound and application thereof in preparation of Lefamulin | |
CN109748787B (en) | A kind of method for preparing artemisinic acid | |
CN110872317A (en) | A kind of preparation method of antitumor drug molecule (+)-Preussin intermediate | |
CN104402852A (en) | Method for synthesizing natural product Tarchonanthuslactone isomer | |
CN116333027A (en) | Preparation method of high-yield glycocholic acid | |
CN106632160A (en) | Methods for preparing semi-synthetic paclitaxel and intermediate thereof | |
CN115819288B (en) | Nitrile oxide, difunctional nitrile oxide and preparation method thereof | |
CN112778189A (en) | (3R,4S) -N-substituent-3-carboxylic acid-4-ethyl pyrrolidine, intermediate and lapatinib | |
CN1308289C (en) | Synthesis method for water-soluble bisamide oxide | |
CN101709047A (en) | Chemical complete synthesis method for 22nd natural amino acid-pyrrolysine | |
CN111303172A (en) | Method for preparing etodolac methyl ester | |
CN115466191B (en) | A method for preparing dendrimers in a continuous flow | |
JPS61205277A (en) | Novel epoxy compound | |
JPS62283982A (en) | Production of bis((alkoxysilyl)alkyl)disulfide | |
CN105131026B (en) | A kind of dual-component catalyst synthesizes N, the method for O-bis- (trimethylsilyl) acetamide | |
JP4200418B2 (en) | Silanols and intermediates thereof, method for producing the same, and method for producing alcohols | |
CN102140124A (en) | Novel synthesis process of capecitabine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230106 |
|
WD01 | Invention patent application deemed withdrawn after publication |